Established by Boehringer Ingelheim in 2015, in collaboration with international stroke experts and the European
Stroke Organisation (ESO), the Acute Networks StrivinG for ExceLlence in Stroke (ANGELS) project has had a major
impact on expanding available treatment for acute stroke patients and improving outcomes in Europe.